Wegovy® (semaglutide) | 4 pens | 2.4 mg

Wegovy semaglutide Weekly Injection – 2.4 mg (4 Pens)

Wegovy semaglutide is an FDA-approved prescription medication indicated for chronic weight management in adults with obesity or overweight who have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol. Designed for once-weekly use, Wegovy® delivers clinically proven weight-loss support when combined with a reduced-calorie diet and increased physical activity.

What Is Wegovy®?

Wegovy® contains semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist that works with your body’s natural appetite-regulating hormones. Each pre-filled pen provides a precise 2.4 mg dose, making weekly administration simple and consistent as part of a medically supervised weight-management plan.

How Semaglutide Supports Weight Loss

GLP-1 Receptor Agonist Mechanism

Semaglutide mimics the action of the GLP-1 hormone, helping to regulate hunger and metabolism. This mechanism helps:

• Reduce appetite and food cravings
• Increase feelings of fullness after meals
• Support healthy blood sugar control
• Promote sustainable, long-term weight management

Wegovy® 2.4 mg Dosage and Administration

Once-Weekly Subcutaneous Injection

Wegovy® is administered once weekly via subcutaneous injection, using easy-to-use pre-filled pens. Product details include:

• Strength: 2.4 mg semaglutide per pen
• Dosage Form: Pre-filled injection pens
• Quantity: 4 pens
• Typical Supply: 28-day regimen

Your healthcare provider will guide you through proper injection technique and dosing schedule.

Who Is Wegovy® For?

Wegovy® is intended for adults who:

• Have obesity or are overweight, and
• Have at least one weight-related condition such as type 2 diabetes, hypertension, or high cholesterol

It is not intended for short-term or cosmetic weight loss and should be used only as prescribed.

Important Safety and Usage Information

Medical Supervision and Dose Escalation

Wegovy® should be used under the guidance of a licensed healthcare provider. A gradual dose-escalation schedule is typically recommended to help minimize side effects and improve tolerability while achieving optimal weight-loss results.

Product Summary

• Product Name: Wegovy® (semaglutide)
• Strength: 2.4 mg per pen
• Quantity: 4 pre-filled pens
• Administration: Weekly subcutaneous injection
• Indication: Chronic weight management in eligible adults